Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Iv Study On The Safety And Efficacy Of The Full Face Applications Of Variable Doses Of 125 To 250 Units Of A Commercial Botulinum Toxin Type A (Dysport®)

NCT01032954 is registered in ClinicalTrials.gov with Hexsel Dermatology Clinic as lead sponsor.

NCT NCT01032954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01032954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Iv Study On The Safety And Efficacy Of The Full Face Applications Of Variable Doses Of 125 To 250 Units Of A Commercial Botulinum Toxin Type A (Dysport®)
Lead sponsor
Hexsel Dermatology Clinic
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2009
Completion date
December 31, 2010
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sun-induced wrinkles